ANGELIA FELTON-WILKS: Open Payments
NPI 1669720041 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,061 in 49 payments from 16 companies in 2025. Trend: 2023 $1,301 · 2024 $1,852 · 2025 $1,061
Food & beverage: $1,061
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $178 |
| Otsuka America Pharmaceutical, Inc. | 9 | $159 |
| Axsome Therapeutics, Inc. | 5 | $120 |
| Novo Nordisk Inc | 4 | $120 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $112 |
| Viatris Specialty LLC | 3 | $84 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $59 |
| Lilly USA, LLC | 3 | $47 |
| Vanda Pharmaceuticals Inc. | 1 | $35 |
| Neurocrine BioSciences, Inc. | 2 | $32 |
Products named: Auvelity, Ozempic, QULIPTA, CAPLYTA, REXULTI, YUPELRI, ABILIFY MAINTENA, VRAYLAR.
Industry payments across WI — which companies pay providers there.
